保脾微创远端胰腺切除术保留或不保留脾血管的短期结局:泛欧洲高容量中心回顾性研究
该多中心回顾性研究纳入29家高容量中心1095例计划保脾的微创远端胰腺切除术患者,比较Kimura术(保留脾血管,634例)与Warshaw术(切除脾血管,244例)的短期结局。两组临床相关脾缺血和主要并发症无显著差异,Warshaw术死亡率较高但敏感性分析后降低,Kimura术手术时间更长但出血更少。
要点
- Kimura与Warshaw保脾微创远端胰腺切除术短期结局相当
- Warshaw术死亡率较高需谨慎解读,敏感性分析后差异减小
- Kimura术手术时间更长但出血量更少
核心结论
- Kimura与Warshaw保脾微创远端胰腺切除术提供相当的短期结局,二次脾切除率和术后并发症率均低。
- 需进一步分析长期结局。
研究设计与样本
- 多中心回顾性研究,纳入8个欧洲国家29家高容量中心(每年≥15例远端胰腺切除术)连续计划保脾的微创远端胰腺切除术患者。
- 共纳入1095例患者,成功保脾878例(80%),其中Kimura术634例,Warshaw术244例。
- 主要结局为缺血导致的二次脾切除和主要并发症(Clavien-Dindo分级≥III)。
- 敏感性分析评估排除在通常(>75%)行Kimura术的中心实施的Warshaw术(「补救」Warshaw术)的影响。
主要发现
- Kimura术与Warshaw术的临床相关脾缺血率分别为0.6%和1.6%(P=0.127),无显著差异。
- Kimura术与Warshaw术的主要并发症率分别为11.5%和14.4%(P=0.308),无显著差异。
- Warshaw术死亡率较高(0.0% vs 1.2%,P=0.023),敏感性分析中降低(0.0% vs 0.6%,P=0.052)。
- Kimura术手术时间更长(202 vs 184分钟,P=0.033),出血量更少(100 vs 150 mL,P<0.001)。
- 非计划脾切除与更高的中转率相关(20.7% vs 5.0%,P<0.001)。
临床怎么用
- 对于计划保脾的微创远端胰腺切除术,Kimura术和Warshaw术均可作为可选术式,短期结局相当。
- 选择术式时可综合考虑手术时间、出血风险及术者经验,Warshaw术死亡率信号需进一步验证。
局限性
- 回顾性研究设计。
- 仅评估短期结局,长期结局需进一步分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare short-term clinical outcomes after Kimura and Warshaw MIDP. BACKGROUND: Spleen preservation during distal pancreatectomy can be achieved by either preservation (Kimura) or resection (Warshaw) of the splenic vessels. Multicenter studies reporting outcomes of Kimura and Warshaw spleen-preserving MIDP are scarce. METHODS: Multicenter retrospective study including consecutive MIDP procedures intended to be spleen-preserving from 29 high-volume centers (≥15 distal pancreatectomies annually) in 8 European countries. Primary outcomes were secondary splenectomy for ischemia and major (Clavien-Dindo grade ≥III) complications. Sensitivity analysis assessed the impact of excluding ("rescue") Warshaw procedures which were performed in centers that typically (>75%) performed Kimura MIDP. RESULTS: Overall, 1095 patients after MIDP were included with successful splenic preservation in 878 patients (80%), including 634 Kimura and 244 Warshaw procedures. Rates of clinically relevant splenic ischemia (0.6% vs 1.6%, P = 0.127) and major complications (11.5% vs 14.4%, P = 0.308) did not differ significantly between Kimura and Warshaw MIDP, respectively. Mortality rates were higher after Warshaw MIDP (0.0% vs 1.2%, P = 0.023), and decreased in the sensitivity analysis (0.0% vs 0.6%, P = 0.052). Kimura MIDP was associated with longer operative time (202 vs 184 minutes, P = 0.033) and less blood loss (100 vs 150 mL, P < 0.001) as compared to Warshaw MIDP. Unplanned splenectomy was associated with a higher conversion rate (20.7% vs 5.0%, P < 0.001). CONCLUSIONS: Kimura and Warshaw spleen-preserving MIDP provide equivalent short-term outcomes with low rates of secondary splenectomy and postoperative morbidity. Further analyses of long-term outcomes are needed.
引用
- Korrel M, Lof S, Al Sarireh B, et al. Short-term Outcomes After Spleen-preserving Minimally Invasive Distal Pancreatectomy With or Without Preservation of Splenic Vessels: A Pan-European Retrospective Study in High-volume Centers. Ann Surg. 2021. PMID: 34091515. doi:10.1097/SLA.0000000000004963
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。